Portal Veterinary medicinal products

The French agency for veterinary medicinal products (Anses-ANMV) organised with Ansm (French agency for human medicines) the second meeting of Heads of Agency (HMA) from 4 to 6 May. The meeting was held at the Palais du Grand Large in Saint Malo with 90 participants from the competent European authorities, the European Commission and the European Medicines Agency (EMA). On the first day, a meeting was organised with stakeholders: representatives of the veterinary medicine industry, veterinarians, farmers and the veterinary diagnosis industry. Among other things, the meeting provided an opportunity to discuss the implementation of the Veterinary Regulations. On May 5th and 6th, the heads of medicines agencies met for a day and a half. At the veterinary session, the European strategy HMA-EMA 2021-2025 on “Big Data” was adopted as well as the Action Plan of the Network of Agencies’ 2025 Strategy. Part of this event was dedicated to medical devices for human use.

The new Regulation (EU) No 2019/6 on veterinary medicinal products provides for the creation of three databases, designed to improve access to and sharing of information on these products. Here is an overview of their objectives.

The new European regulation on veterinary pharmaceuticals came into force on 28 January 2022. The Director of the French Agency for Veterinary Medicinal Products (ANMV), Jean-Pierre Orand, assesses what will change.

European Antibiotic Awareness Day is taking place on 18 November 2021. For this occasion, ANSES is publishing the results of several monitoring programmes that it carries out to prevent the emergence and spread of antibiotic-resistant bacteria in farm and domestic animals in France. Below is a review of some key findings with Jean-Yves Madec, Scientific Director for antimicrobial resistance and Head of the French surveillance network for antimicrobial resistance in pathogenic bacteria of animal origin (RESAPATH), Gérard Moulin, Deputy Director of the French Agency for Veterinary Medicinal Products (ANMV), and Agnès Perrin-Guyomard, Deputy Head of the National Reference Laboratory for antimicrobial resistance.